首页 > 最新文献

Survey of ophthalmology最新文献

英文 中文
Inner retinal surface abnormalities: Imaging phenotypes, quantitative features, and mechanistic insights across surgical and nonsurgical conditions. 视网膜内表面异常:成像表型,定量特征,以及手术和非手术条件下的机制见解。
IF 5.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-03-11 DOI: 10.1016/j.survophthal.2026.03.004
Alberto Quarta, Alessandro Feo, Giacomo Boscia, Alfonso Savastano, Francesco Boscia, Mario R Romano, Rodolfo Mastropasqua

Advances in cross-sectional and en face optical coherence tomography have revealed a spectrum of subtle inner retinal changes that occur in both surgical and non-surgical conditions. Among these, inner retinal dimples (IRDs), also referred to as dissociated optic nerve fiber layer (DONFL) appearance, concentric macular dark spots (CMDS), and transient swollen arcuate nerve fiber layer (SANFL) have been described in eyes undergoing internal limiting membrane (ILM) peeling, most commonly for macular hole or epiretinal membrane while paravascular inner retinal defects (PIRD), micro-holes, and clefts have been reported in highly myopic eyes and tractional conditions even without prior surgery. The multiplicity of terms, some modality-dependent, others descriptive of etiology has obscured the relationships among these entities, causing confusion in clinical interpretation and research communication. Herein, we propose a hypothesis-driven conceptual and terminological framework intended to reconcile these disparate observations within a coherent schema grounded in anatomy and imaging phenotype while recognizing that the available evidence remains predominantly retrospective and heterogeneous. By reviewing multimodal imaging studies we clarify that postoperative IRDs, DONFL, CMDS, and SANFL may reflect a remodeling response of the inner retina (largely due to ILM removal/peeling, either surgical or spontaneous) whereas PIRD and its variants stem from chronic biomechanical or tractional stress. The review examines their morphological characteristics, temporal evolution, and available data on structure-function correlations. Standardizing nomenclature and interpretation will enhance clarity in both surgical outcomes assessment and clinical management of myopic or tractional retinal disease.

横断和正面光学相干断层扫描(OCT)的进展揭示了在手术和非手术条件下发生的细微视网膜内变化的光谱。其中,视网膜内窝(IRDs),也被称为游离的视神经纤维层(DONFL)外观,同心性黄斑黑斑(CMDS)和短暂性肿胀弓状神经纤维层(SANFL)在发生内限制膜(ILM)剥落的眼睛中被描述,最常见的是黄斑孔(MH)或视网膜前膜(ERM),而血管旁视网膜内缺陷(PIRD),微孔,据报道,在高度近视和牵拉条件下,即使没有事先手术,裂缝也会出现。术语的多样性,一些模式依赖,其他描述病因模糊了这些实体之间的关系,导致临床解释和研究交流的混乱。在此,我们提出了一个假设驱动的概念和术语框架,旨在在解剖学和成像表型基础上的连贯图式中调和这些不同的观察结果,同时认识到现有证据仍然主要是回顾性的和异质性的。通过回顾多模态成像研究,我们澄清了术后ird、DONFL、CMDS和SANFL可能反映了内视网膜的重塑反应(主要是由于ILM的移除/剥离,无论是手术还是自发的),而PIRD及其变体源于慢性生物力学或牵引应力。本文综述了它们的形态特征、时间演变以及结构-功能相关性的现有数据。标准化的命名和解释将提高近视或牵引性视网膜疾病的手术结果评估和临床管理的清晰度。
{"title":"Inner retinal surface abnormalities: Imaging phenotypes, quantitative features, and mechanistic insights across surgical and nonsurgical conditions.","authors":"Alberto Quarta, Alessandro Feo, Giacomo Boscia, Alfonso Savastano, Francesco Boscia, Mario R Romano, Rodolfo Mastropasqua","doi":"10.1016/j.survophthal.2026.03.004","DOIUrl":"10.1016/j.survophthal.2026.03.004","url":null,"abstract":"<p><p>Advances in cross-sectional and en face optical coherence tomography have revealed a spectrum of subtle inner retinal changes that occur in both surgical and non-surgical conditions. Among these, inner retinal dimples (IRDs), also referred to as dissociated optic nerve fiber layer (DONFL) appearance, concentric macular dark spots (CMDS), and transient swollen arcuate nerve fiber layer (SANFL) have been described in eyes undergoing internal limiting membrane (ILM) peeling, most commonly for macular hole or epiretinal membrane while paravascular inner retinal defects (PIRD), micro-holes, and clefts have been reported in highly myopic eyes and tractional conditions even without prior surgery. The multiplicity of terms, some modality-dependent, others descriptive of etiology has obscured the relationships among these entities, causing confusion in clinical interpretation and research communication. Herein, we propose a hypothesis-driven conceptual and terminological framework intended to reconcile these disparate observations within a coherent schema grounded in anatomy and imaging phenotype while recognizing that the available evidence remains predominantly retrospective and heterogeneous. By reviewing multimodal imaging studies we clarify that postoperative IRDs, DONFL, CMDS, and SANFL may reflect a remodeling response of the inner retina (largely due to ILM removal/peeling, either surgical or spontaneous) whereas PIRD and its variants stem from chronic biomechanical or tractional stress. The review examines their morphological characteristics, temporal evolution, and available data on structure-function correlations. Standardizing nomenclature and interpretation will enhance clarity in both surgical outcomes assessment and clinical management of myopic or tractional retinal disease.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147460003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral retinal degenerations: A review of peripheral optical coherence tomography applications in their diagnosis and visualization. 外周视网膜变性:外周光学相干断层扫描在其诊断和可视化中的应用综述。
IF 5.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-03-11 DOI: 10.1016/j.survophthal.2026.03.006
Clara Rizzo, Stefano Mercuri, Maria Cristina Savastano, Andrea Govetto, Cristina Nicolosi, Giulio Vicini, Francesco Faraldi, Gianni Virgili, Fabrizio Giansanti, Daniela Bacherini

Optical coherence tomography (OCT) has transformed retinal imaging, primarily focusing on the posterior pole; however, its application in assessing peripheral retinal lesions is an evolving field. Recent advances in widefield (WF) and ultra-widefield (UWF) OCT technology have significantly expanded the ability to image the peripheral retina, allowing for improved detection and characterization of peripheral retinal lesions. We evaluate the effectiveness of OCT in identifying peripheral retinal lesions, assessing vitreoretinal adhesions and tractions, aiding differential diagnosis, and guiding treatment strategies among studies published between 2006 and 2024. WF and UWF OCT have significantly enhanced the visualization and documentation of peripheral retinal abnormalities, facilitating more precise detection of retinal breaks, lattice degeneration, and vitreoretinal traction. These advancements have influenced clinical decisions, ranging from conservative monitoring to laser therapy or surgical intervention. Furthermore, OCT has provided valuable insights into the pathophysiology of these retinal disorders; however, several challenges persist, including the absence of standardized imaging protocols and variability in the interpretation of morphological findings. While peripheral OCT imaging enhances diagnostic accuracy and clinical management, broader adoption requires standardization of acquisition techniques and diagnostic criteria. We explore the role of WF and UWF OCT in visualizing peripheral retinal degenerations, describing their hallmark features on OCT, evaluating their diagnostic value, clinical impact, and current limitations. Future research should focus on refining imaging protocols, developing automated diagnostic tools, and evaluating the prognostic significance of peripheral OCT findings to improve patient outcomes.

光学相干断层扫描(OCT)已经改变了视网膜成像,主要聚焦于后极;然而,它在视网膜周围病变评估中的应用是一个不断发展的领域。宽视场(WF)和超宽视场(UWF) OCT技术的最新进展极大地扩展了周围视网膜成像的能力,从而改进了周围视网膜病变的检测和表征。我们评估了OCT在识别周围视网膜病变、评估玻璃体视网膜粘连和牵拉、辅助鉴别诊断和指导治疗策略方面的有效性。WF和UWF OCT显著增强了周围视网膜异常的可视化和记录,有助于更精确地检测视网膜断裂、晶格变性和玻璃体视网膜牵拉。这些进步影响了临床决策,从保守监测到激光治疗或手术干预。此外,OCT为这些视网膜疾病的病理生理学提供了有价值的见解;然而,一些挑战仍然存在,包括缺乏标准化的成像协议和形态学发现解释的可变性。虽然外周OCT成像提高了诊断准确性和临床管理,但更广泛的采用需要标准化的采集技术和诊断标准。我们探讨了WF和UWF OCT在观察周围视网膜变性中的作用,描述了它们在OCT上的标志性特征,评估了它们的诊断价值、临床影响和当前的局限性。未来的研究应侧重于完善成像方案,开发自动化诊断工具,评估外周OCT结果的预后意义,以改善患者的预后。
{"title":"Peripheral retinal degenerations: A review of peripheral optical coherence tomography applications in their diagnosis and visualization.","authors":"Clara Rizzo, Stefano Mercuri, Maria Cristina Savastano, Andrea Govetto, Cristina Nicolosi, Giulio Vicini, Francesco Faraldi, Gianni Virgili, Fabrizio Giansanti, Daniela Bacherini","doi":"10.1016/j.survophthal.2026.03.006","DOIUrl":"https://doi.org/10.1016/j.survophthal.2026.03.006","url":null,"abstract":"<p><p>Optical coherence tomography (OCT) has transformed retinal imaging, primarily focusing on the posterior pole; however, its application in assessing peripheral retinal lesions is an evolving field. Recent advances in widefield (WF) and ultra-widefield (UWF) OCT technology have significantly expanded the ability to image the peripheral retina, allowing for improved detection and characterization of peripheral retinal lesions. We evaluate the effectiveness of OCT in identifying peripheral retinal lesions, assessing vitreoretinal adhesions and tractions, aiding differential diagnosis, and guiding treatment strategies among studies published between 2006 and 2024. WF and UWF OCT have significantly enhanced the visualization and documentation of peripheral retinal abnormalities, facilitating more precise detection of retinal breaks, lattice degeneration, and vitreoretinal traction. These advancements have influenced clinical decisions, ranging from conservative monitoring to laser therapy or surgical intervention. Furthermore, OCT has provided valuable insights into the pathophysiology of these retinal disorders; however, several challenges persist, including the absence of standardized imaging protocols and variability in the interpretation of morphological findings. While peripheral OCT imaging enhances diagnostic accuracy and clinical management, broader adoption requires standardization of acquisition techniques and diagnostic criteria. We explore the role of WF and UWF OCT in visualizing peripheral retinal degenerations, describing their hallmark features on OCT, evaluating their diagnostic value, clinical impact, and current limitations. Future research should focus on refining imaging protocols, developing automated diagnostic tools, and evaluating the prognostic significance of peripheral OCT findings to improve patient outcomes.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147460032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical coherence tomography angiography in pediatric and adult populations: A comprehensive review. 光学相干断层血管造影在儿童和成人人群:一个全面的回顾。
IF 5.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-03-11 DOI: 10.1016/j.survophthal.2026.03.009
Anna M Busza, Clayton E Lyons, Nikoo Hamzeh, Saeed Mohammadi, Manjot K Gill

Optical coherence tomography angiography (OCT-A) is a non-invasive retinal imaging tool with expanding clinical and research applications, including potential uses as a biomarker for systemic diseases. The influence of age on OCT-A parameters, however, remains incompletely understood. To address this, we conducted a comprehensive review across seven databases, screening 271 full-text articles, of which 156 met inclusion criteria. Extracted data included participant demographics, study design, OCT-A device type, measured parameters, and outcomes across retinal layers in the macula and optic nerve head. Normative OCT-A values for pediatric and older adult populations were also reviewed. Evidence consistently demonstrated an age-related decline in macular vessel density among adults, even after accounting for signal strength. In contrast, pediatric studies showed variable associations between age and vascular parameters. Across all populations, foveal avascular zone size remained largely unaffected by age. These findings highlight the importance of considering age when interpreting OCT-A metrics in both clinical and research settings.

光学相干断层扫描血管造影(OCT-A)是一种非侵入性视网膜成像工具,具有广泛的临床和研究应用,包括作为全身性疾病的生物标志物的潜在用途。然而,年龄对OCT-A参数的影响仍不完全清楚。为了解决这个问题,我们对7个数据库进行了全面的综述,筛选了271篇全文文章,其中156篇符合纳入标准。提取的数据包括参与者人口统计、研究设计、OCT-A装置类型、测量参数以及黄斑和视神经头视网膜层的结果。儿童和老年人的标准OCT-A值也进行了审查。证据一致表明,成年人黄斑血管密度与年龄相关的下降,即使在考虑信号强度之后。相比之下,儿科研究显示年龄和血管参数之间存在可变关联。在所有人群中,中央凹无血管区大小基本上不受年龄的影响。这些发现强调了在临床和研究环境中解释OCT-A指标时考虑年龄的重要性。
{"title":"Optical coherence tomography angiography in pediatric and adult populations: A comprehensive review.","authors":"Anna M Busza, Clayton E Lyons, Nikoo Hamzeh, Saeed Mohammadi, Manjot K Gill","doi":"10.1016/j.survophthal.2026.03.009","DOIUrl":"https://doi.org/10.1016/j.survophthal.2026.03.009","url":null,"abstract":"<p><p>Optical coherence tomography angiography (OCT-A) is a non-invasive retinal imaging tool with expanding clinical and research applications, including potential uses as a biomarker for systemic diseases. The influence of age on OCT-A parameters, however, remains incompletely understood. To address this, we conducted a comprehensive review across seven databases, screening 271 full-text articles, of which 156 met inclusion criteria. Extracted data included participant demographics, study design, OCT-A device type, measured parameters, and outcomes across retinal layers in the macula and optic nerve head. Normative OCT-A values for pediatric and older adult populations were also reviewed. Evidence consistently demonstrated an age-related decline in macular vessel density among adults, even after accounting for signal strength. In contrast, pediatric studies showed variable associations between age and vascular parameters. Across all populations, foveal avascular zone size remained largely unaffected by age. These findings highlight the importance of considering age when interpreting OCT-A metrics in both clinical and research settings.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147460084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
William W. Cooper and his epidemiological study "On the conical cornea" of 1850. 威廉·w·库珀和他1850年的流行病学研究《论锥形角膜》。
IF 5.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-03-10 DOI: 10.1016/j.survophthal.2026.03.003
Tristan Jurkiewicz, Anne-Sophie Marty

Purpose: We present the life and work of William White Cooper, with a focus on his 1850 study On the conical cornea, the earliest known multicentre epidemiological investigation of keratoconus. We contextualise Cooper's contribution within mid-19th-century ophthalmology, reassessing his findings in light of modern epidemiological knowledge.

Methods: Historical research was conducted using Gallica (the digital platform of the National Library of France (BnF)) and the historical resources of The Lancet website. The keywords used were 'conical cornea' or 'keratoconus,' which were the most common names for keratoconus.

Results: William White Cooper, a leading Victorian ophthalmic surgeon and later Surgeon-Oculist in Ordinary to Queen Victoria, conducted what appears to be the first epidemiological study of keratoconus, nearly a century before the earliest study typically cited in modern literature. Drawing on data from multiple ophthalmic hospitals across England, Scotland, Ireland, and Macao, Cooper compiled prevalence figures from over 200,000 examined patients between 1814 and 1850. Prevalence rates, recalculated for comparison with modern standards, varied markedly between regions: from 0 in Edinburgh to 254.0 cases per 100,000 in Plymouth, with an overall prevalence of 85.92 per 100,000 for the United Kingdom. The highest prevalence was observed in Macao (324.15 per 100,000), leading Cooper to hypothesise that warmer climates might favor the occurrence of keratoconus. Despite the diagnostic limitations of the period, these values are strikingly close to those reported in parts of modern Europe, underscoring the scale and relevance of his pioneering work.

Conclusion: Cooper's 1850 investigation represents the earliest known multicentre epidemiological study of keratoconus, predating modern reports by nearly a century. Despite methodological limitations inherent to the mid-19th century, his findings anticipated contemporary prevalence patterns and introduced the hypothesis of environmental influences on disease occurrence. This work not only enriches the historical record of keratoconus, but also highlights the enduring value of early clinical observation in shaping epidemiological understanding.

目的:介绍威廉·怀特·库珀的生平和工作,重点介绍他1850年对圆锥角膜的研究,这是已知最早的圆锥角膜多中心流行病学调查。本文旨在将库珀对19世纪中期眼科的贡献置于背景中,根据现代流行病学知识重新评估他的发现。方法:使用Gallica(法国国家图书馆数字平台)和the Lancet网站的历史资源进行历史研究。使用的关键词是“圆锥角膜”或“圆锥角膜”,这是圆锥角膜最常见的名称。结果:威廉·怀特·库珀(William White Cooper)是维多利亚时代著名的眼科医生,后来成为维多利亚女王时期的普通眼科医生,他进行了第一次关于圆锥角膜的流行病学研究,比现代文献中最早的研究早了近一个世纪。根据来自英格兰、苏格兰、爱尔兰和澳门多家眼科医院的数据,库珀汇编了1814年至1850年间接受检查的20多万名患者的患病率数据。重新计算的流行率与现代标准进行了比较,不同地区的流行率差异很大:从爱丁堡的0例到普利茅斯的254.0例/ 10万例,英国的总体流行率为85.92 / 10万。澳门的患病率最高(每10万人中有324.15人),这使得Cooper假设温暖的气候可能有利于圆锥角膜的发生。尽管那个时期的诊断存在局限性,但这些价值与现代欧洲部分地区的报告惊人地接近,突显了他开创性工作的规模和相关性。结论:库珀1850年的调查代表了已知最早的圆锥角膜多中心流行病学研究,比现代报告早了近一个世纪。尽管19世纪中期固有的方法局限性,但他的发现预测了当代的流行模式,并提出了环境影响疾病发生的假设。这项工作不仅丰富了圆锥角膜的历史记录,而且突出了早期临床观察在形成流行病学认识方面的持久价值。
{"title":"William W. Cooper and his epidemiological study \"On the conical cornea\" of 1850.","authors":"Tristan Jurkiewicz, Anne-Sophie Marty","doi":"10.1016/j.survophthal.2026.03.003","DOIUrl":"10.1016/j.survophthal.2026.03.003","url":null,"abstract":"<p><strong>Purpose: </strong>We present the life and work of William White Cooper, with a focus on his 1850 study On the conical cornea, the earliest known multicentre epidemiological investigation of keratoconus. We contextualise Cooper's contribution within mid-19th-century ophthalmology, reassessing his findings in light of modern epidemiological knowledge.</p><p><strong>Methods: </strong>Historical research was conducted using Gallica (the digital platform of the National Library of France (BnF)) and the historical resources of The Lancet website. The keywords used were 'conical cornea' or 'keratoconus,' which were the most common names for keratoconus.</p><p><strong>Results: </strong>William White Cooper, a leading Victorian ophthalmic surgeon and later Surgeon-Oculist in Ordinary to Queen Victoria, conducted what appears to be the first epidemiological study of keratoconus, nearly a century before the earliest study typically cited in modern literature. Drawing on data from multiple ophthalmic hospitals across England, Scotland, Ireland, and Macao, Cooper compiled prevalence figures from over 200,000 examined patients between 1814 and 1850. Prevalence rates, recalculated for comparison with modern standards, varied markedly between regions: from 0 in Edinburgh to 254.0 cases per 100,000 in Plymouth, with an overall prevalence of 85.92 per 100,000 for the United Kingdom. The highest prevalence was observed in Macao (324.15 per 100,000), leading Cooper to hypothesise that warmer climates might favor the occurrence of keratoconus. Despite the diagnostic limitations of the period, these values are strikingly close to those reported in parts of modern Europe, underscoring the scale and relevance of his pioneering work.</p><p><strong>Conclusion: </strong>Cooper's 1850 investigation represents the earliest known multicentre epidemiological study of keratoconus, predating modern reports by nearly a century. Despite methodological limitations inherent to the mid-19th century, his findings anticipated contemporary prevalence patterns and introduced the hypothesis of environmental influences on disease occurrence. This work not only enriches the historical record of keratoconus, but also highlights the enduring value of early clinical observation in shaping epidemiological understanding.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative pathogenesis and management of orbital/conjunctival and gastric MALT lymphoma: Microbial drivers, molecular mechanisms, and therapeutic implications. 眼眶/结膜和胃MALT淋巴瘤的发病机制和治疗比较:微生物驱动、分子机制和治疗意义。
IF 5.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-03-10 DOI: 10.1016/j.survophthal.2026.03.005
I-Ming Wang, I-Lun Tsai

Mucosa-associated lymphoid tissue (MALT) lymphoma is a subtype of indolent extranodal B-cell non-Hodgkin lymphoma. Orbital and conjunctival MALT lymphomas (OAML) are the most common primary ocular adnexal lymphomas, while gastric MALT lymphoma remains a prototypical site linked to Helicobacter pylori infection. Despite the disparate anatomical locations, mounting evidence suggests a shared pathogenesis, including chronic antigenic stimulation, lymphoid accumulation, and genetic events. We explore the epidemiologic, pathophysiologic, and molecular connections between OAML and gastric MALT lymphoma, with particular emphasis on the therapeutic implications. The role of H. pylori as a driver of gastric lymphomagenesis is well-established, and antibiotic eradication therapy has revolutionized treatment. By contrast, the evidence for microbial triggers and antibiotic responsiveness in OAML remains equivocal, although Chlamydia psittaci has been proposed in some populations. We comprehensively evaluate treatment modalities for OAML, including watchful waiting, antibiotic therapy, low-dose radiotherapy, immunochemotherapy (e.g., rituximab, bendamustine), and targeted agents. The differences in natural history, treatment response, and relapse patterns between gastric and ocular MALTomas are reviewed, and a proposed treatment algorithm is presented. Finally, we highlight knowledge gaps and future directions, including molecular profiling, predictive biomarkers, and microbiome-targeted interventions.

粘膜相关淋巴组织(MALT)淋巴瘤是一种惰性结外b细胞非霍奇金淋巴瘤。眼眶和结膜MALT淋巴瘤(OAML)是最常见的原发性眼附件淋巴瘤,而胃MALT淋巴瘤仍然是与幽门螺杆菌感染相关的典型部位。尽管不同的解剖位置,越来越多的证据表明一个共同的发病机制,包括慢性抗原刺激,淋巴细胞积累和遗传事件。这篇综述探讨了OAML和胃MALT淋巴瘤之间的流行病学、病理生理学和分子联系,特别强调了治疗意义。幽门螺杆菌作为胃淋巴瘤形成的驱动因素的作用是公认的,抗生素根除治疗已经彻底改变了治疗方法。相比之下,尽管在一些人群中提出了鹦鹉热衣原体,但OAML中微生物触发和抗生素反应的证据仍然模棱两可。我们全面评估OAML的治疗方式,包括观察等待、抗生素治疗、低剂量放疗、免疫化疗(如利妥昔单抗、苯达莫司汀)和靶向药物。本文回顾了胃和眼MALTomas在自然史、治疗反应和复发模式方面的差异,并提出了一种拟议的治疗算法。最后,我们强调了知识差距和未来的方向,包括分子分析,预测性生物标志物和微生物组靶向干预。
{"title":"Comparative pathogenesis and management of orbital/conjunctival and gastric MALT lymphoma: Microbial drivers, molecular mechanisms, and therapeutic implications.","authors":"I-Ming Wang, I-Lun Tsai","doi":"10.1016/j.survophthal.2026.03.005","DOIUrl":"10.1016/j.survophthal.2026.03.005","url":null,"abstract":"<p><p>Mucosa-associated lymphoid tissue (MALT) lymphoma is a subtype of indolent extranodal B-cell non-Hodgkin lymphoma. Orbital and conjunctival MALT lymphomas (OAML) are the most common primary ocular adnexal lymphomas, while gastric MALT lymphoma remains a prototypical site linked to Helicobacter pylori infection. Despite the disparate anatomical locations, mounting evidence suggests a shared pathogenesis, including chronic antigenic stimulation, lymphoid accumulation, and genetic events. We explore the epidemiologic, pathophysiologic, and molecular connections between OAML and gastric MALT lymphoma, with particular emphasis on the therapeutic implications. The role of H. pylori as a driver of gastric lymphomagenesis is well-established, and antibiotic eradication therapy has revolutionized treatment. By contrast, the evidence for microbial triggers and antibiotic responsiveness in OAML remains equivocal, although Chlamydia psittaci has been proposed in some populations. We comprehensively evaluate treatment modalities for OAML, including watchful waiting, antibiotic therapy, low-dose radiotherapy, immunochemotherapy (e.g., rituximab, bendamustine), and targeted agents. The differences in natural history, treatment response, and relapse patterns between gastric and ocular MALTomas are reviewed, and a proposed treatment algorithm is presented. Finally, we highlight knowledge gaps and future directions, including molecular profiling, predictive biomarkers, and microbiome-targeted interventions.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ophthalmic manifestations in preterm children without retinopathy of prematurity: A review. 无早产儿视网膜病变的早产儿眼部表现综述。
IF 5.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-03-10 DOI: 10.1016/j.survophthal.2026.03.001
Kourosh Sheibani, Kia Bayat, Zhale Rajavi, Saeid Abdi, Firouze Hatami, Sina Khosravi Mirzaei, Homayoun Nikkhah, Azadeh Haseli-Mofrad, Mohammad Hasan Shahriari, Niloufar Bineshfar, Hamideh Sabbaghi

We synthesized current evidence on the spectrum of ophthalmic alterations in prematurely born children without retinopathy of prematurity (ROP). A literature review was conducted in accordance with PRISMA guidelines. Scopus, PubMed, Web of Science, and Cochrane Library were searched for English-language studies published between 2000 and 2025. Eligible studies included observational designs reporting ophthalmic outcomes in infants born before 37 weeks of gestation without ROP. A total of 32 studies consisting of 4,548 individuals were investigated. Data were qualitatively synthesized across visual, refractive, anterior segment, and posterior segment domains. Mean visual acuity in preterm children without ROP ranged from -0.06 to 0.16 LogMAR and was generally comparable to term peers. Stereoacuity was reduced but showed improvement with age. Strabismus was reported in 5-20% of cases, increasing with age, and most commonly presented as esotropia. Nystagmus incidence ranged from 0-14%. Anisometropia was reported in 1.4-16.7% of preterm children without ROP, with one study demonstrating a higher prevalence compared to term peers. Hyperopia was highly prevalent, ranging from 20.9% to 86.2%, while astigmatism was reported in 14.1-65.1% of cases. Astigmatism predominated at one year of age, whereas hyperopia became the most common refractive error by six years. Hyperopia tends to increase with age, astigmatism gradually declines, and myopia rates remain relatively stable. Anterior segment findings in infancy included greater central corneal thickness, smaller corneal diameter, reduced axial length, shallower anterior chamber depth, and increased lens thickness. Posterior segment alterations included thicker central macula and focal thinning of the retinal nerve fiber layer in some reports. Premature birth, even in the absence of ROP, is independently associated with persistent structural and functional ophthalmic alterations. These findings highlight the need for long-term surveillance and early ophthalmologic intervention in this population.

我们综合了目前关于无早产儿视网膜病变(ROP)的早产儿眼部改变谱的证据。根据PRISMA指南进行文献综述。Scopus、PubMed、Web of Science和Cochrane Library检索了2000年至2025年间发表的英语研究。符合条件的研究包括观察性设计,报告妊娠37周前出生的无ROP婴儿的眼科结果。总共调查了32项研究,包括4,548人。定性地综合了视觉、屈光、前节和后节区域的数据。没有ROP的早产儿的平均视力范围为-0.06至0.16 LogMAR,一般与足月同龄人相当。立体视敏度随年龄增长而降低,但有改善。5-20%的病例有斜视,随年龄增长而增加,最常表现为内斜视。眼球震颤发生率为0-14%。据报道,1.4-16.7%的无ROP早产儿有屈光参差,一项研究表明,与足月同龄人相比,屈光参差的患病率更高。远视发生率为20.9% ~ 86.2%,散光发生率为14.1% ~ 65.1%。散光在一岁时占主导地位,而远视在六岁时成为最常见的屈光不正。远视随年龄增长而增加,散光逐渐减弱,近视率保持相对稳定。婴儿期前段的表现包括角膜中央厚度增大,角膜直径减小,角膜轴长减小,前房深度变浅,晶状体厚度增加。后段病变包括中央黄斑变厚和视网膜神经纤维层局灶性变薄。早产,即使在没有ROP的情况下,也与持续的眼科结构和功能改变独立相关。这些发现强调了对这一人群进行长期监测和早期眼科干预的必要性。
{"title":"Ophthalmic manifestations in preterm children without retinopathy of prematurity: A review.","authors":"Kourosh Sheibani, Kia Bayat, Zhale Rajavi, Saeid Abdi, Firouze Hatami, Sina Khosravi Mirzaei, Homayoun Nikkhah, Azadeh Haseli-Mofrad, Mohammad Hasan Shahriari, Niloufar Bineshfar, Hamideh Sabbaghi","doi":"10.1016/j.survophthal.2026.03.001","DOIUrl":"https://doi.org/10.1016/j.survophthal.2026.03.001","url":null,"abstract":"<p><p>We synthesized current evidence on the spectrum of ophthalmic alterations in prematurely born children without retinopathy of prematurity (ROP). A literature review was conducted in accordance with PRISMA guidelines. Scopus, PubMed, Web of Science, and Cochrane Library were searched for English-language studies published between 2000 and 2025. Eligible studies included observational designs reporting ophthalmic outcomes in infants born before 37 weeks of gestation without ROP. A total of 32 studies consisting of 4,548 individuals were investigated. Data were qualitatively synthesized across visual, refractive, anterior segment, and posterior segment domains. Mean visual acuity in preterm children without ROP ranged from -0.06 to 0.16 LogMAR and was generally comparable to term peers. Stereoacuity was reduced but showed improvement with age. Strabismus was reported in 5-20% of cases, increasing with age, and most commonly presented as esotropia. Nystagmus incidence ranged from 0-14%. Anisometropia was reported in 1.4-16.7% of preterm children without ROP, with one study demonstrating a higher prevalence compared to term peers. Hyperopia was highly prevalent, ranging from 20.9% to 86.2%, while astigmatism was reported in 14.1-65.1% of cases. Astigmatism predominated at one year of age, whereas hyperopia became the most common refractive error by six years. Hyperopia tends to increase with age, astigmatism gradually declines, and myopia rates remain relatively stable. Anterior segment findings in infancy included greater central corneal thickness, smaller corneal diameter, reduced axial length, shallower anterior chamber depth, and increased lens thickness. Posterior segment alterations included thicker central macula and focal thinning of the retinal nerve fiber layer in some reports. Premature birth, even in the absence of ROP, is independently associated with persistent structural and functional ophthalmic alterations. These findings highlight the need for long-term surveillance and early ophthalmologic intervention in this population.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of conbercept, ranibizumab and laser in retinopathy of prematurity: a systematic review and network meta-analysis. conberept、雷尼单抗和激光治疗早产儿视网膜病变的疗效和安全性:系统综述和网络荟萃分析。
IF 5.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-03-06 DOI: 10.1016/j.survophthal.2026.03.002
Dandan Linghu, Xuemei Zhu, Jianhong Liang, Yong Cheng

This systematic review evaluates conbercept, ranibizumab, and laser therapy for retinopathy of prematurity (ROP) through 53 studies (14 RCTs, 29 retrospective, 10 single-arm) involving 8,787 eyes. Primary endpoints included inactive ROP rates (resolution of plus disease/vascular tortuosity), disease regression, recurrence rates, and retreatment needs, with safety assessments covering ocular complications (retinal detachment, vitreous hemorrhage) and systemic events (apnea, arrhythmias). Exploratory analyses examined conbercept dosing regimens (0.15mg, 0.25mg, 0.3mg). Conbercept showed superior cumulative efficacy (SUCRA=0.815) versus laser (0.533) and ranibizumab (0.152), though initial treatment responses were comparable. Ranibizumab had higher recurrence (RR=3.62, 95%CI:1.31-11.64) and retreatment rates (RR=2.31, 95%CI:1.18-5.55) than laser, which ranked best for preventing recurrence (SUCRA=0.792). Conbercept's ocular AE rate (3.85%) was lower than laser (9.82%) and ranibizumab (5.03%), with fewer systemic complications (3.49% NICU admissions vs 42.17% for laser). Dose-response analysis revealed 0.25mg conbercept balanced efficacy (82.70% inactivity) and safety (3.84% AEs), while 0.3mg showed peak efficacy (90.7%) but limited safety data. Higher doses reduced recurrence (22.97% at 0.15mg vs 17.00% at 0.25mg).

本系统综述通过涉及8,787只眼睛的53项研究(14项随机对照试验,29项回顾性研究,10项单臂研究)评估了雷尼单抗、雷尼单抗和激光治疗早产儿视网膜病变(ROP)的疗效。主要终点包括无活性ROP率(疾病/血管弯曲的消退)、疾病消退、复发率和再治疗需求,安全性评估包括眼部并发症(视网膜脱离、玻璃体出血)和全身事件(呼吸暂停、心律失常)。探索性分析检查了概念给药方案(0.15mg, 0.25mg, 0.3mg)。Conbercept的累积疗效(SUCRA=0.815)优于激光(0.533)和雷尼单抗(0.152),尽管初始治疗反应相当。雷尼单抗的复发率(RR=3.62, 95%CI:1.31-11.64)和复治率(RR=2.31, 95%CI:1.18-5.55)均高于激光,在预防复发方面位居第一(SUCRA=0.792)。Conbercept的眼部AE发生率(3.85%)低于激光(9.82%)和雷尼单抗(5.03%),系统性并发症更少(NICU入院率为3.49%,激光为42.17%)。剂量反应分析显示,0.25mg的概念平衡了疗效(82.70%无活性)和安全性(3.84% ae), 0.3mg的疗效达到峰值(90.7%),但安全性数据有限。高剂量降低了复发率(0.15mg时22.97% vs 0.25mg时17.00%)。
{"title":"Efficacy and safety of conbercept, ranibizumab and laser in retinopathy of prematurity: a systematic review and network meta-analysis.","authors":"Dandan Linghu, Xuemei Zhu, Jianhong Liang, Yong Cheng","doi":"10.1016/j.survophthal.2026.03.002","DOIUrl":"https://doi.org/10.1016/j.survophthal.2026.03.002","url":null,"abstract":"<p><p>This systematic review evaluates conbercept, ranibizumab, and laser therapy for retinopathy of prematurity (ROP) through 53 studies (14 RCTs, 29 retrospective, 10 single-arm) involving 8,787 eyes. Primary endpoints included inactive ROP rates (resolution of plus disease/vascular tortuosity), disease regression, recurrence rates, and retreatment needs, with safety assessments covering ocular complications (retinal detachment, vitreous hemorrhage) and systemic events (apnea, arrhythmias). Exploratory analyses examined conbercept dosing regimens (0.15mg, 0.25mg, 0.3mg). Conbercept showed superior cumulative efficacy (SUCRA=0.815) versus laser (0.533) and ranibizumab (0.152), though initial treatment responses were comparable. Ranibizumab had higher recurrence (RR=3.62, 95%CI:1.31-11.64) and retreatment rates (RR=2.31, 95%CI:1.18-5.55) than laser, which ranked best for preventing recurrence (SUCRA=0.792). Conbercept's ocular AE rate (3.85%) was lower than laser (9.82%) and ranibizumab (5.03%), with fewer systemic complications (3.49% NICU admissions vs 42.17% for laser). Dose-response analysis revealed 0.25mg conbercept balanced efficacy (82.70% inactivity) and safety (3.84% AEs), while 0.3mg showed peak efficacy (90.7%) but limited safety data. Higher doses reduced recurrence (22.97% at 0.15mg vs 17.00% at 0.25mg).</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147378524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Double layer sign in chorioretinal diseases: Clinical significance and implications from multimodal imaging 绒毛膜视网膜疾病的双层征象:临床意义和多模态成像的意义。
IF 5.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2025-09-20 DOI: 10.1016/j.survophthal.2025.09.017
Alberto Quarta , Alessandro Feo , Giulia Corradetti , Marko M. Popovic , SriniVas R. Sadda
The double-layer sign (DLS) is an emerging optical coherence tomography (OCT) biomarker of growing diagnostic and prognostic relevance in retinal and chorioretinal diseases, including age-related macular degeneration, pachychoroid spectrum disorders. Multimodal imaging, particularly OCT angiography (OCTA), has enhanced our ability to characterize DLS and its role in disease progression and treatment response. DLS is identified as a separation between the retinal pigment epithelium (RPE) and Bruch's membrane, with overlapping phenotypic presentations including flat irregular pigment epithelial detachment (FIPED) and shallow irregular retinal pigment epithelial elevation. These signs are often associated with vascularized lesions that demonstrate increased DLS thickness, irregular contours, and heterogeneous reflectivity. OCTA offers superior sensitivity and specificity for detecting subclinical macular neovascularization compared to dye-based angiography, which may underestimate nonexudative neovascularization. Additionally, indocyanine green angiography remains crucial for identifying branching vascular networks and polypoidal lesions, especially in polypoidal choroidal vasculopathy. In pachychoroid diseases, such as chronic central serous chorioretinopathy, the presence of FIPED/DLS can indicate underlying neovascularization, which may benefit from combination therapy with anti-vascular endothelial growth factor agents. We discuss the multimodal imaging characteristics, prognostic significance, and clinical relevance of DLS across various retinal and chorioretinal disorders.
双层征象(DLS)是一种新兴的光学相干断层扫描(OCT)生物标志物,在视网膜和绒毛膜视网膜疾病(包括年龄相关性黄斑变性(AMD)、厚脉络膜谱系疾病)的诊断和预后方面具有日益重要的意义。多模态成像,特别是OCT血管造影(OCTA),增强了我们表征DLS及其在疾病进展和治疗反应中的作用的能力。DLS被认为是视网膜色素上皮(RPE)和Bruch膜之间的分离,具有重叠的表型表现,包括扁平不规则色素上皮脱离(FIPED)和浅不规则RPE升高。这些征象通常与血管化病变相关,表现为DLS厚度增加,轮廓不规则,反射率不均匀。与染料血管造影相比,OCTA在检测亚临床黄斑新生血管方面具有更高的灵敏度和特异性,而染料血管造影可能低估了非渗出性新生血管。此外,吲哚菁绿血管造影对于识别分支血管网络和息肉样病变仍然至关重要,特别是在息肉样脉络膜血管病变中。在厚脉络膜疾病中,如慢性中枢性浆液性脉络膜视网膜病变,FIPED/DLS的存在可能表明潜在的新生血管形成,这可能受益于抗血管内皮生长因子药物的联合治疗。我们讨论了多模态成像特征,预后意义,以及各种视网膜和绒毛膜视网膜疾病的DLS的临床相关性。
{"title":"Double layer sign in chorioretinal diseases: Clinical significance and implications from multimodal imaging","authors":"Alberto Quarta ,&nbsp;Alessandro Feo ,&nbsp;Giulia Corradetti ,&nbsp;Marko M. Popovic ,&nbsp;SriniVas R. Sadda","doi":"10.1016/j.survophthal.2025.09.017","DOIUrl":"10.1016/j.survophthal.2025.09.017","url":null,"abstract":"<div><div>The double-layer sign (DLS) is an emerging optical coherence tomography (OCT) biomarker of growing diagnostic and prognostic relevance in retinal and chorioretinal diseases, including age-related macular degeneration, pachychoroid spectrum disorders. Multimodal imaging, particularly OCT angiography (OCTA), has enhanced our ability to characterize DLS and its role in disease progression and treatment response. DLS is identified as a separation between the retinal pigment epithelium (RPE) and Bruch's membrane, with overlapping phenotypic presentations including flat irregular pigment epithelial detachment (FIPED) and shallow irregular retinal pigment epithelial elevation. These signs are often associated with vascularized lesions that demonstrate increased DLS thickness, irregular contours, and heterogeneous reflectivity. OCTA offers superior sensitivity and specificity for detecting subclinical macular neovascularization compared to dye-based angiography, which may underestimate nonexudative neovascularization. Additionally, indocyanine green angiography remains crucial for identifying branching vascular networks and polypoidal lesions, especially in polypoidal choroidal vasculopathy. In pachychoroid diseases, such as chronic central serous chorioretinopathy, the presence of FIPED/DLS can indicate underlying neovascularization, which may benefit from combination therapy with anti-vascular endothelial growth factor agents. We discuss the multimodal imaging characteristics, prognostic significance, and clinical relevance of DLS across various retinal and chorioretinal disorders.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"71 2","pages":"Pages 456-466"},"PeriodicalIF":5.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical and surgical approaches to prevent corneal graft rejection in high-risk recipients 预防高危受者角膜移植排斥反应的医学和外科方法
IF 5.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2025-10-01 DOI: 10.1016/j.survophthal.2025.09.024
Sepehr Feizi MD, MSc, Firouze Hatami MD, Sina Khosravi Mirzaei MD, Kia Bayat MD
A substantial number of corneal transplantations are performed in the vascularized and inflamed environments of high-risk recipients, which increases the risk of graft rejection. Managing high-risk keratoplasty is challenging and encompasses numerous pre-, intra-, and post-operative measures. Preoperative measures include treating ocular surface inflammation and corneal neovascularization. Intraoperative measures mainly involve performing lamellar keratoplasty, if possible, to reduce the loads of alloantigens introduced to the recipient’s immune system. The key step in the prevention of immunologic rejection in high-risk recipients is the administration of topical and systemic immunosuppressive medications for a long term. Topical corticosteroids are frequently administered after corneal transplantation; however, they are insufficient to prevent graft rejection following high-risk keratoplasty. In such cases, various systemic immunosuppressive medications can be employed with inconstant success rates. Nonetheless, these agents can result in potentially serious and sometimes life-threatening adverse reactions. Furthermore, the ideal method of administration, dosage, frequency, and duration of application of these medications have not been identified for individual cases of high-risk keratoplasty. New strategies, including targeted biological treatments and tolerance-inducing protocols, may hold promise in decreasing the risk of corneal graft rejection in high-risk settings without the adverse reactions of systemic immunosuppressive treatment.
大量的角膜移植是在高风险受者的血管化和炎症环境中进行的,这增加了移植排斥的风险。管理高风险角膜移植手术是具有挑战性的,包括许多术前、术中和术后措施。术前措施包括治疗眼表炎症和角膜新生血管。术中措施主要包括进行板层角膜移植术,如果可能的话,以减少引入受体免疫系统的异体抗原负荷。预防高危受体免疫排斥反应的关键步骤是长期给予局部和全身免疫抑制药物。角膜移植后经常使用局部皮质类固醇;然而,它们不足以预防高风险角膜移植术后的移植排斥反应。在这种情况下,可以使用各种全身免疫抑制药物,成功率不稳定。尽管如此,这些药物可能导致潜在的严重,有时甚至危及生命的不良反应。此外,这些药物的理想给药方法、剂量、频率和持续时间还没有被确定为高危角膜移植术的个别病例。新的策略,包括靶向生物治疗和耐受诱导方案,可能有望降低高风险环境中角膜移植排斥的风险,而不会出现全身免疫抑制治疗的不良反应。
{"title":"Medical and surgical approaches to prevent corneal graft rejection in high-risk recipients","authors":"Sepehr Feizi MD, MSc,&nbsp;Firouze Hatami MD,&nbsp;Sina Khosravi Mirzaei MD,&nbsp;Kia Bayat MD","doi":"10.1016/j.survophthal.2025.09.024","DOIUrl":"10.1016/j.survophthal.2025.09.024","url":null,"abstract":"<div><div>A substantial number of corneal transplantations are performed in the vascularized and inflamed environments of high-risk recipients, which increases the risk of graft rejection. Managing high-risk keratoplasty is challenging and encompasses numerous pre-, intra-, and post-operative measures. Preoperative measures include treating ocular surface inflammation and corneal neovascularization. Intraoperative measures mainly involve performing lamellar keratoplasty, if possible, to reduce the loads of alloantigens introduced to the recipient’s immune system. The key step in the prevention of immunologic rejection in high-risk recipients is the administration of topical and systemic immunosuppressive medications for a long term. Topical corticosteroids are frequently administered after corneal transplantation; however, they are insufficient to prevent graft rejection following high-risk keratoplasty. In such cases, various systemic immunosuppressive medications can be employed with inconstant success rates. Nonetheless, these agents can result in potentially serious and sometimes life-threatening adverse reactions. Furthermore, the ideal method of administration, dosage, frequency, and duration of application of these medications have not been identified for individual cases of high-risk keratoplasty. New strategies, including targeted biological treatments and tolerance-inducing protocols, may hold promise in decreasing the risk of corneal graft rejection in high-risk settings without the adverse reactions of systemic immunosuppressive treatment.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"71 2","pages":"Pages 674-684"},"PeriodicalIF":5.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145226019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical trials and quasi-experimental studies in the treatment of noninfectious retinal vasculitis: A systematic review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) – Report 4 非感染性视网膜血管炎治疗的临床试验和准实验研究:来自国际葡萄膜炎研究组(IUSG)视网膜血管炎研究(修订)的系统综述-报告4。
IF 5.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2025-09-20 DOI: 10.1016/j.survophthal.2025.09.013
Paola Saboya-Galindo , Carlos Cifuentes-González , William Rojas-Carabali , Germán Mejía-Salgado , Yong Le Tong , Ikhwanuliman Putera , Xin Ying Rachel Song , Cheong Fu Yuan Walter , Zhang Shengjuan , Reo Chan , Rina La Distia Nora , Jyotirmay Biswas , Sapna Gangaputra , Jose S Pulido , John H Kempen , Quan Dong Nguyen , Alejandra de-la-Torre , Vishali Gupta , James T. Rosenbaum , Rupesh Agrawal , Uwe Pleyer
This systematic review evaluates clinical trials and quasi-experimental studies reporting diagnostic criteria, disease activity scoring systems (including Disease Activity Index (DAI), Total Inflammatory Activity Index (TIAI), and Total Adjusted Disease Activity Index (TADAI), and others), and therapeutic strategies used in noninfectious retinal vasculitis (RV), aiming to consolidate current evidence on treatment response and effectiveness measures. Of 5533 articles screened (PROSPERO: CRD42023489232), 15 studies met the inclusion criteria. Most were conducted in Asia (73.3 %) and focused on Behçet disease (60 %) or Eales disease (27 %). RV was diagnosed clinically in all studies, while half incorporated fluorescein angiography to confirm vascular inflammation through leakage, staining, or occlusion; however, definitions of RV were highly variable, often inferred rather than explicitly stated, and lacked standardization. This diagnostic inconsistency, combined with limited imaging data, undermines comparability across studies. Disease activity was assessed using outdated composite indices such as the DAI, TIAI, and TADAI, which lack external validation and fail to capture key clinical features such as macular ischemia or capillary non-perfusion. Best corrected visual acuity, although frequently reported, was confounded by unrelated factors such as cataracts or macular scarring. Therapeutic strategies included systemic corticosteroids, immunosuppressants (e.g., methotrexate, azathioprine), and biologics (e.g., infliximab, interferon-alpha). Treatment selection was heterogeneous, and several regimens—such as cyclophosphamide-azathioprine combinations—do not align with current standards of care. Due to variability in study design and outcome reporting, no pooled effect estimates, or statistical comparisons were conducted. Treatment outcomes were synthesized descriptively based on individual study findings. Current evidence in RV clinical trials is outdated and lacks diagnostic and therapeutic standardization. There is a particular need for RV-specific definitions, validated disease activity and response indices, and contemporary therapeutic trials to guide clinical management and improve outcome comparability.
本系统综述评估了报告诊断标准、疾病活动性评分系统(包括疾病活动性指数(DAI)、总炎症活动性指数(TIAI)和总调整疾病活动性指数(TADAI)等)以及用于非感染性视网膜血管炎(RV)的治疗策略的临床试验和准实验研究,旨在巩固目前关于治疗反应和有效性措施的证据。在筛选的5533篇文章中(PROSPERO: CRD42023489232),有15项研究符合纳入标准。大多数研究在亚洲进行(73.3%),重点是behaperet病(60%)或Eales病(27%)。所有研究均临床诊断为RV,其中一半采用荧光素血管造影,通过渗漏、染色或闭塞来确认血管炎症;然而,RV的定义是高度可变的,通常是推断而不是明确说明,并且缺乏标准化。这种诊断的不一致性,加上有限的成像数据,破坏了研究之间的可比性。疾病活动性的评估使用过时的复合指数,如DAI、TIAI和TADAI,这些指数缺乏外部验证,无法捕捉关键的临床特征,如黄斑缺血或毛细血管非灌注。最佳矫正视力,虽然经常报道,是混淆的不相关因素,如白内障或黄斑疤痕。治疗策略包括全身皮质类固醇、免疫抑制剂(如甲氨蝶呤、硫唑嘌呤)和生物制剂(如英夫利昔单抗、干扰素- α)。治疗选择是不均匀的,一些方案——如环磷酰胺-硫唑嘌呤联合用药——不符合当前的治疗标准。由于研究设计和结果报告的可变性,没有进行汇总效应估计或统计比较。治疗结果根据个别研究结果进行描述性综合。目前RV临床试验的证据是过时的,缺乏诊断和治疗的标准化。我们特别需要rv特异性的定义、经过验证的疾病活动性和反应指数,以及当代治疗试验来指导临床管理和提高结果的可比性。
{"title":"Clinical trials and quasi-experimental studies in the treatment of noninfectious retinal vasculitis: A systematic review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) – Report 4","authors":"Paola Saboya-Galindo ,&nbsp;Carlos Cifuentes-González ,&nbsp;William Rojas-Carabali ,&nbsp;Germán Mejía-Salgado ,&nbsp;Yong Le Tong ,&nbsp;Ikhwanuliman Putera ,&nbsp;Xin Ying Rachel Song ,&nbsp;Cheong Fu Yuan Walter ,&nbsp;Zhang Shengjuan ,&nbsp;Reo Chan ,&nbsp;Rina La Distia Nora ,&nbsp;Jyotirmay Biswas ,&nbsp;Sapna Gangaputra ,&nbsp;Jose S Pulido ,&nbsp;John H Kempen ,&nbsp;Quan Dong Nguyen ,&nbsp;Alejandra de-la-Torre ,&nbsp;Vishali Gupta ,&nbsp;James T. Rosenbaum ,&nbsp;Rupesh Agrawal ,&nbsp;Uwe Pleyer","doi":"10.1016/j.survophthal.2025.09.013","DOIUrl":"10.1016/j.survophthal.2025.09.013","url":null,"abstract":"<div><div>This systematic review evaluates clinical trials and quasi-experimental studies reporting diagnostic criteria, disease activity scoring systems (including Disease Activity Index (DAI), Total Inflammatory Activity Index (TIAI), and Total Adjusted Disease Activity Index (TADAI), and others), and therapeutic strategies used in noninfectious retinal vasculitis (RV), aiming to consolidate current evidence on treatment response and effectiveness measures. Of 5533 articles screened (PROSPERO: CRD42023489232), 15 studies met the inclusion criteria. Most were conducted in Asia (73.3 %) and focused on Behçet disease (60 %) or Eales disease (27 %). RV was diagnosed clinically in all studies, while half incorporated fluorescein angiography to confirm vascular inflammation through leakage, staining, or occlusion; however, definitions of RV were highly variable, often inferred rather than explicitly stated, and lacked standardization. This diagnostic inconsistency, combined with limited imaging data, undermines comparability across studies. Disease activity was assessed using outdated composite indices such as the DAI, TIAI, and TADAI, which lack external validation and fail to capture key clinical features such as macular ischemia or capillary non-perfusion. Best corrected visual acuity, although frequently reported, was confounded by unrelated factors such as cataracts or macular scarring. Therapeutic strategies included systemic corticosteroids, immunosuppressants (e.g., methotrexate, azathioprine), and biologics (e.g., infliximab, interferon-alpha). Treatment selection was heterogeneous, and several regimens—such as cyclophosphamide-azathioprine combinations—do not align with current standards of care. Due to variability in study design and outcome reporting, no pooled effect estimates, or statistical comparisons were conducted. Treatment outcomes were synthesized descriptively based on individual study findings. Current evidence in RV clinical trials is outdated and lacks diagnostic and therapeutic standardization. There is a particular need for RV-specific definitions, validated disease activity and response indices, and contemporary therapeutic trials to guide clinical management and improve outcome comparability.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"71 2","pages":"Pages 545-559"},"PeriodicalIF":5.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Survey of ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1